title: Enhanced proliferative response of hepatocytes to combined inhalation and oral exposures to N,N-dimethylformamide in male rats.
abstract: Male Wistar rats were exposed by inhalation to N,N-dimethylformamide (DMF) at 0 (control), 200 or 400 ppm (v/v) for 6 hr/day, 5 days/week and 4 weeks, and each inhalation group received DMF-formulated drinking water at 0, 800, 1,600 or 3,200 ppm (w/w) for 24 hr/day, 7 days/week and 4 weeks. Both the combined inhalation and oral exposures and the single-route exposure through inhalation or ingestion induced centrilobular hypertrophy and single-cell necrosis of hepatocytes, increased plasma levels of alanine aminotransferase (ALT), increased percentage of proliferating cell nuclear antigen (PCNA)-positive hepatocytes without glutathione-S-transferase placental form (GST-P)-positive liver foci, and increased relative liver weight. Those hepatic parameters of the DMF-induced effects were classified into hypertrophic, necrotic and proliferative responses according to the pathological characteristics of affected liver. While magnitudes of the hypertrophic and necrotic responses were linearly increased with an increase in amounts of DMF uptake in the single-route exposure groups, those dose-response relationships tended to level off in the combined-exposure groups. Saturation of the hypertrophic and necrotic responses at high dose levels might be attributed to suppression of the metabolic conversion of DMF to its toxic metabolites. Percentage of PCNA-stained hepatocytes classified as the proliferative response was increased more steeply in the combined-exposure groups than in the single-route exposure groups. It was suggested that the proliferative response of hepatocytes to the combined exposures would be greater than that which would be expected under an assumption of additivity for the component proliferative responses to the single-route exposures through inhalation and ingestion.
authors.affiliation: Japan Bioassay Research Center, Japan Industrial Safety and Health Association, Kanagawa. h-obayashi@jisha.or.jp
authors.forename: Hisao
authors.initials: H
authors.lastname: Ohbayashi
authors.forename: Kazunori
authors.initials: K
authors.lastname: Yamazaki
authors.forename: Shigetoshi
authors.initials: S
authors.lastname: Aiso
authors.forename: Kasuke
authors.initials: K
authors.lastname: Nagano
authors.forename: Shoji
authors.initials: S
authors.lastname: Fukushima
authors.forename: Hisayoshi
authors.initials: H
authors.lastname: Ohta
mesh_terms: D000284:Administration, Oral; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects; D004126:Dimethylformamide / Q000008:administration & dosage / Q000633:toxicity*; D051549:Glutathione S-Transferase pi / Q000032:analysis; D022781:Hepatocytes / Q000187:drug effects* / Q000473:pathology; D019570:Inhalation Exposure; D008297:Male; D009929:Organ Size / Q000187:drug effects; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D018809:Proliferating Cell Nuclear Antigen; D004126:Dimethylformamide; D051549:Glutathione S-Transferase pi; C496558:Gstp1 protein, rat; D000410:Alanine Transaminase